# Oncotype DX DCIS: Impact on Radiotherapy Decision Making

> **NCT06046664** · NA · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 78 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** ONCOTYPE DX DCIS test

## Key facts

- **NCT ID:** NCT06046664
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-07
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06046664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06046664, "Oncotype DX DCIS: Impact on Radiotherapy Decision Making". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06046664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*